YSB Inc.

Research YSB Inc. (B1S) on Bullrun: market cap EUR 245.64M, P/E 11.9, dividend yield 3.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 245.64M; P/E is 11.9; dividend yield is 3.8%.

Peer valuation comparison

Latest P/E is 11.87x versus a Healthcare sector median of 24.46x (51.5% below).

Latest dividend yield is 3.78% versus a Healthcare sector median of 2.11% (79.1% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CNY 20.97BCNY 152.97MCNY 619.46M11.0%0.22CNY 706.87MCNY 327.45MCNY 2.44B
FY2024CNY 17.90BCNY 30.01MCNY 632.46M10.1%0.05CNY 1.01BCNY 233.51MCNY 2.32B
FY2023CNY 16.97B-CNY 3.21BCNY 433.65M10.3%-8.26CNY 673.87MCNY 209.66MCNY 1.92B
FY2022CNY 14.27B-CNY 1.50BCNY 54.49M10.1%-2.37CNY 835.39MCNY 180.55M-CNY 4.35B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24EUR 245.64M11.93.9%0.01

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.01 EUR, yield 3.8%.

YearDividends/share
FY20250.01 CNY

About YSB Inc.

YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is YSB Inc.'s market cap?

YSB Inc.'s market capitalization is EUR 245.64M.

What is YSB Inc.'s P/E ratio?

YSB Inc.'s price-to-earnings (P/E) ratio is 11.9.

Does YSB Inc. pay a dividend?

YSB Inc. has a dividend yield of 3.8%.

What does YSB Inc. do?

YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations.